EC Number   |
Expression |
Reference |
|---|
  2.4.3.2 | down |
among the five mammalian homologs of the NF-jB family, RelB RNAi most effectively inhibits the expression of ST3Gal I |
745103 |
| 2.4.3.2 | down |
among the five mammalian homologs of the NF-jB family, RelB RNAi most effectively inhibits the expression of ST3Gal II |
745103 |
| 2.4.3.2 | up |
expression of ST3Gal I is mildly induced by phorbol-12-myristate-13-acetate. The expression of both ST3Gal I reaches to the peak within 12 h. phorbol-12-myristate-13-acetate-induced ST3Gal I expression is inhibited by NF-kappaB decoy oligodeoxynucleotides but not by AP-1 decoy oligodeoxynucleotides |
745103 |
| 2.4.3.2 | up |
expression of ST3Gal II is mildly induced by phorbol-12-myristate-13-acetate. The expression of both ST3Gal II reaches to the peak within 12 h. phorbol-12-myristate-13-acetate-induced ST3Gal II expression is inhibited by NF-kappaB decoy oligodeoxynucleotides but not by AP-1 decoy oligodeoxynucleotides |
745103 |
| 2.4.3.2 | up |
highly expressed in most pancreatic adenocarcinoma tissues |
745082 |
| 2.4.3.2 | up |
induction of COX-2 in the MDAMB-231 breast cancer cell line results in the increased expression of ST3Gal-I, leading to increased sialylation of the substrate of ST3Gal-I |
745288 |
| 2.4.3.2 | up |
its increased expression level is closely related to renal carcinogenesis |
745272 |
| 2.4.3.2 | up |
PGE2, one of the final products of the cyclooxygenase-2 (COX-2) pathway, can induce the mRNA expression of the sialyltransferase ST3Gal-I, resulting in increased sialyltransferase activity |
745288 |
| 2.4.3.2 | up |
the number of ST3Gal IV-expressing neurons in the anterior thalamic nuclei increases from 2% to 21% in a time-dependent manner during epileptogenesis |
745588 |
| 2.4.3.2 | up |
tumour necrosis factor induces the expression of the sialyltransferase ST3Gal IV in human bronchial mucosa via MSK1/2 protein kinases |
744266 |
